ERBB2 and neoplasm: Tumor cells exhibited strong and diffuse mutant-type p53 positivity (Figure 7a), ultra-low HER2/Neu expression (Figure 7b,c), and a Ki-67 proliferation index of approximately 50% (Figure 8a).